publication date: Oct. 25, 2019

In Brief

Sleckman to lead O’Neal Comprehensive Cancer Center

Barry Paul Sleckman was named director of the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham.

Sleckman, an associate director of the Meyer Cancer Center at Weill Cornell Medicine, will begin his new role at UAB on Jan. 6, 2020.

“The O’Neal Comprehensive Cancer Center must catalyze important cancer discoveries across diverse centers, departments and schools on the UAB campus, and then translate these discoveries into innovative cancer therapies in close partnership with the UAB Health System. I’m excited to be coming to Birmingham and am ready to get to work,” Sleckman said in a statement.

Sleckman’s research is focused on novel pathways that function in DNA double strand break repair, including one that prevents DNA breaks from being resolved as chromosomal translocations or deletions that can lead to cancer. His laboratory was the first to show that the cellular response to DNA double strand breaks can regulate cell-type-specific pathways involved in normal cellular functions. These pathways can be disrupted, for example, in cancer patients receiving genotoxic therapies such as radiation.

Sleckman completed his medical degree and doctorate in immunology at Harvard Medical School. He completed his residency in internal medicine and fellowship in infectious diseases at the Brigham and Women’s Hospital. In addition to his role as associate director, Sleckman held positions as professor of pathology and laboratory medicine and professor of microbiology and immunology at Weill Cornell Medicine, and prior to this as associate director of the Siteman Cancer Center at Washington University for 10 years.

After completing his postdoctoral training in molecular immunology in the laboratory of Frederick Alt at Boston Children’s Hospital, Sleckman … Continue reading Sleckman to lead O’Neal Comprehensive Cancer Center

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.